Recombinant Hepatitis B vaccine - PT Bio Farma
Latest Information Update: 22 Apr 2022
At a glance
- Originator PT Bio Farma
- Class DNA vaccines; Hepatitis B vaccines; Synthetic vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Hepatitis B
Most Recent Events
- 22 Apr 2022 No development reported - Phase-II/III for Hepatitis B (In adolescents, In children, Prevention, In adults) in Indonesia (IM)
- 16 Jul 2020 PT Bio Farma completes a phase I trial for Hepatitis B (Prevention, In children, In adults, In adolescents) in Indonesia (IM) (NCT04188223)
- 28 Feb 2020 PT Bio Farma completes the phase II/III trial in Hepatitis B (In children, In adults, In adolescents, Prevention) in Indonesia (NCT03919578)